Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients.
about
Identification of TMEM208 and PQLC2 as reference genes for normalizing mRNA expression in colorectal cancer treated with aspirin.The viral restriction factor tetherin prevents leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) from association with beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and enhances autophagy and mitophagy.Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis.Transforming Growth Factor TGFβ Increases Levels of Microtubule-Associated Protein MAP1S and Autophagy Flux in Pancreatic Ductal AdenocarcinomasDefects in MAP1S-mediated autophagy cause reduction in mouse lifespans especially when fibronectin is overexpressedFast clearance of lipid droplets through MAP1S-activated autophagy suppresses clear cell renal cell carcinomas and promotes patient survivalDefects in MAP1S-mediated autophagy turnover of fibronectin cause renal fibrosis.Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation.Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6.The prognostic value of p62 in solid tumor patients: a meta-analysis.Spermidine Prolongs Lifespan and Prevents Liver Fibrosis and Hepatocellular Carcinoma by Activating MAP1S-Mediated Autophagy.Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer.Molecular and cellular mechanisms of castration resistant prostate cancer.High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancerCytoplasmic SQSTM1/ P62 Accumulation Predicates a Poor Prognosis in Patients with Malignant TumorElevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer
P2860
Q33618460-8911ACD3-A300-4323-BE40-35BFDC519CAEQ35172704-8C2620C3-D7E7-44B3-839F-DFA0C24DBC83Q35480244-5899AF8C-2E59-482E-8E67-E9E372C9F50DQ35841939-10948EE9-F946-42D2-8E08-17C8867F6E12Q36665479-06F9E76A-DBB4-4237-B7AD-42EAE1152830Q36905895-77F514C0-CD6D-41EC-909D-23D7C1F5E6D4Q37062491-07C1E7CE-1651-4556-9FC9-C4BBDC09F14CQ47133921-D1B77047-39E1-4278-B32B-C6C6BF41C1EBQ48136525-6E2BA1F1-D357-4145-8402-EA7B19318D1FQ49436326-49C62EC8-F9DF-403A-B524-7B5D0564A6DBQ51068347-82F78066-FABB-4CF5-B323-573D788E3CB5Q51238587-53EF2188-4B5E-4E44-976A-045704AF2F6FQ52608488-6599CC50-F3D8-49E0-A13B-9A51FEE8A151Q58572138-C4972344-662A-441C-8148-5F62745B1008Q58597767-BFB8D73C-D95A-4EA8-A576-552DB1C54004Q58733629-251497C9-221C-4907-A2B5-56D1FC8D6B32
P2860
Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 July 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autophagy defects suggested by ...... s of prostate cancer patients.
@en
Autophagy defects suggested by ...... s of prostate cancer patients.
@nl
type
label
Autophagy defects suggested by ...... s of prostate cancer patients.
@en
Autophagy defects suggested by ...... s of prostate cancer patients.
@nl
prefLabel
Autophagy defects suggested by ...... s of prostate cancer patients.
@en
Autophagy defects suggested by ...... s of prostate cancer patients.
@nl
P2093
P2860
P356
P1476
Autophagy defects suggested by ...... s of prostate cancer patients.
@en
P2093
Funeng Jiang
Huichan He
Leyuan Liu
Weide Zhong
Weiqiang Yang
P2860
P304
P356
10.1002/MC.22193
P577
2014-07-07T00:00:00Z